Zenas Biopharma (ZBIO)'s 30-day implied volatility (IV30) was 64.8% at the close on November 19, 2026, up from 60.8% the day before, against a 52-week range of 55.0% to 174.6%. Its 20-day historical volatility was 63.3%.
Data as of November 19, 2026.